Skip to main content
Top
Published in: Supportive Care in Cancer 9/2005

01-09-2005 | Short Communication

Development of a prognostic index in cancer patients with low performance status

Authors: José Ferraz Gonçalves, Isabel Costa, Carolina Monteiro

Published in: Supportive Care in Cancer | Issue 9/2005

Login to get access

Abstract

Background

Prognosis is a very important medical function. In advanced cancer it is also important to help planning the care to deliver to individual patients with more accuracy, in the process of decision about the opportunity for some interventions and in the selection of patients for clinical trials. Although the performance status indexes are by themselves prognostic factors, among patients in all stages there are wide variations in survival. In what concerns bedridden patients, survival varies between hours and months. Therefore it would be useful to develop a method which could allow a more precise estimation of the length of survival in these patients.

Patients and methods

We have studied prospectively 110 bedridden patients exploring six variables: consciousness level, recognition of familiar people, continence and capacity to communicate, to eat and to swallow. Each factor was scored on a scale of 0 to 2. Our aim was to construct a classification system with the sum of the scores of the variables significantly correlated with survival. The cut-off-points were calculated using the percentiles ≤25, 50 and ≥75 according to the method of Altman et al. (J Natl Cancer Inst 86:829–835. 1994).

Results

Four of the variables were significantly associated with survival, and an index with three stages was constructed with the sum of these four variables: I–0 to 3; II–4 to 6; III–7 to 8. The differences in survival among the stages are statistically significant and the probability of survival at the 7th, 30th, 60th, and 90th days is also different.

Conclusion

The differences in survival observed among the stages can be clinically relevant to the establishment of a prognostic to individual patients.
Literature
1.
go back to reference Evans C, McCarthy M (1985) Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet 1:1204–1206 Evans C, McCarthy M (1985) Prognostic uncertainty in terminal care: can the Karnofsky index help? Lancet 1:1204–1206
2.
go back to reference Maltoni M, Nanni O, Derni S et al (1994) Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients. Eur J Cancer 30A:764–766 Maltoni M, Nanni O, Derni S et al (1994) Clinical prediction of survival is more accurate than the Karnofsky performance status in estimating life span of terminally ill cancer patients. Eur J Cancer 30A:764–766
3.
go back to reference Mor V, Laliberte L, Morris JN, Wiemann M (1984) The Karnofsky performance status: an examination of its reliability and validity in a research setting. Cancer 53:2002–2007PubMed Mor V, Laliberte L, Morris JN, Wiemann M (1984) The Karnofsky performance status: an examination of its reliability and validity in a research setting. Cancer 53:2002–2007PubMed
4.
go back to reference Yates JW, Chalmer B, McKegney P (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220–2224 Yates JW, Chalmer B, McKegney P (1980) Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45:2220–2224
5.
go back to reference Maltoni M, Pirovano M, Nanni O, Labianca R, Amadori D (1994) Prognostic factors in terminal cancer patients. Eur J Palliat Care 1:122–125 Maltoni M, Pirovano M, Nanni O, Labianca R, Amadori D (1994) Prognostic factors in terminal cancer patients. Eur J Palliat Care 1:122–125
6.
go back to reference Forster LE, Lynn J (1988) Predicting life span for applicants to inpatient hospice. Arch Intern Med 148:2540–2543 Forster LE, Lynn J (1988) Predicting life span for applicants to inpatient hospice. Arch Intern Med 148:2540–2543
7.
go back to reference Oxenham D, Cornbleet MA (1998) Accuracy of prediction of survival by different professional groups in a hospice. Palliat Med 12:117–118 Oxenham D, Cornbleet MA (1998) Accuracy of prediction of survival by different professional groups in a hospice. Palliat Med 12:117–118
8.
go back to reference Hardy J, Turner R, Edmonds P, A’Hern R (1997) Prediction of survival in patients referred to a palliative care unit. Palliat Med 11:73 Hardy J, Turner R, Edmonds P, A’Hern R (1997) Prediction of survival in patients referred to a palliative care unit. Palliat Med 11:73
9.
go back to reference Parkes CM (1972) Accuracy of predictions of survival in later stages of cancer. BMJ 2:29–31 Parkes CM (1972) Accuracy of predictions of survival in later stages of cancer. BMJ 2:29–31
10.
go back to reference Viganò A, Dorgan M, Buckingham J, Bruera E, Suarez-Almanzor ME (2000) Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14:363–374 Viganò A, Dorgan M, Buckingham J, Bruera E, Suarez-Almanzor ME (2000) Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14:363–374
11.
go back to reference Llobera J, Esteva M, Rifà J et al (2000) Terminal cancer: duration and prediction of survival time. Eur J Cancer 36:2036–2043 Llobera J, Esteva M, Rifà J et al (2000) Terminal cancer: duration and prediction of survival time. Eur J Cancer 36:2036–2043
12.
go back to reference Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J (1992) Estimates of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 7:82–86 Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J (1992) Estimates of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 7:82–86
13.
go back to reference Reuben DB, Mor V, Hiris J (1988) Clinical symptoms and length of survival in patients with terminal care. Arch Intern Med 148:1586–1591 Reuben DB, Mor V, Hiris J (1988) Clinical symptoms and length of survival in patients with terminal care. Arch Intern Med 148:1586–1591
14.
go back to reference Nekolaichuk CL, Bruera E, Spachynski K, MacEachern T, Hanson J, Maguire TO (1999) A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliat Med 13:311–323 Nekolaichuk CL, Bruera E, Spachynski K, MacEachern T, Hanson J, Maguire TO (1999) A comparison of patient and proxy symptom assessments in advanced cancer patients. Palliat Med 13:311–323
15.
go back to reference Glare P, Virik K (2001) Independet prospective validation of the PaP Score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage 22:891–898 Glare P, Virik K (2001) Independet prospective validation of the PaP Score in terminally ill patients referred to a hospital-based palliative medicine consultation service. J Pain Symptom Manage 22:891–898
16.
go back to reference Walsh D, Rybicki L, Nelson KA, Donnelly S (2002) Symptoms and prognosis in advanced cancer. Support Care Cancer 10:385–388 Walsh D, Rybicki L, Nelson KA, Donnelly S (2002) Symptoms and prognosis in advanced cancer. Support Care Cancer 10:385–388
17.
go back to reference Maltoni M, Pirovano M, Scarpi E et al (1995) Prediction of survival of patients terminally ill with cancer. Cancer 75:2613–2622 Maltoni M, Pirovano M, Scarpi E et al (1995) Prediction of survival of patients terminally ill with cancer. Cancer 75:2613–2622
18.
go back to reference Maltoni M, Nanni O, Pirovano M et al (1999) Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage 17:240–247 Maltoni M, Nanni O, Pirovano M et al (1999) Successful validation of the palliative prognostic score in terminally ill cancer patients. J Pain Symptom Manage 17:240–247
19.
go back to reference Caraceni A, Nanni O, Maltoni M et al (2000) Impact of delirium on the short term prognosis of advanced cancer patients. Cancer 89:1145–1149 Caraceni A, Nanni O, Maltoni M et al (2000) Impact of delirium on the short term prognosis of advanced cancer patients. Cancer 89:1145–1149
20.
go back to reference Fainsinger RL, Tapper M, Bruera E (1993) A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 9:4–8 Fainsinger RL, Tapper M, Bruera E (1993) A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 9:4–8
21.
go back to reference Romagnoli A, Rapin CH (1991) Valeur pronostique de certains paramètres biologiques chez des sujects âgés hospitalisés. Age Nutri 2:130–136 Romagnoli A, Rapin CH (1991) Valeur pronostique de certains paramètres biologiques chez des sujects âgés hospitalisés. Age Nutri 2:130–136
22.
go back to reference Fülöp T, Herrmann F, Rapin CH (1991) Prognostic role of serum prealbumin levels in elderly patients at admission to a geriatric hospital. Arch Gerontol Geriatr 12:31–39 Fülöp T, Herrmann F, Rapin CH (1991) Prognostic role of serum prealbumin levels in elderly patients at admission to a geriatric hospital. Arch Gerontol Geriatr 12:31–39
23.
go back to reference den Daas N (1995) Estimating length of survival in end-stage cancer: a review of the literature. J Pain Symptom Manage 10:548–555 den Daas N (1995) Estimating length of survival in end-stage cancer: a review of the literature. J Pain Symptom Manage 10:548–555
24.
go back to reference Ferraz Gonçalves JA (2001) A Portuguese palliative care unit. Support Care Cancer 9:4–7 Ferraz Gonçalves JA (2001) A Portuguese palliative care unit. Support Care Cancer 9:4–7
25.
go back to reference Altman DG, Lousen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal” cut-off-points in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835 Altman DG, Lousen B, Sauerbrei W, Schumacher M (1994) Dangers of using “optimal” cut-off-points in the evaluation of prognostic factors. J Natl Cancer Inst 86:829–835
26.
go back to reference Glare P, Virik K, Jones M et al (2003) A systematic review of physicians’ survival prediction in terminally ill cancer patients. BMJ 327:195–200CrossRefPubMed Glare P, Virik K, Jones M et al (2003) A systematic review of physicians’ survival prediction in terminally ill cancer patients. BMJ 327:195–200CrossRefPubMed
Metadata
Title
Development of a prognostic index in cancer patients with low performance status
Authors
José Ferraz Gonçalves
Isabel Costa
Carolina Monteiro
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 9/2005
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0800-0

Other articles of this Issue 9/2005

Supportive Care in Cancer 9/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine